Mutations in Amyloid b Precursor Protein (APP) and in genes that regulate APP processing -such as PSEN1/2 and ITM2b/BRI2 -cause familial dementia, such Familial Alzheimer disease (FAD), Familial Danish (FDD) and British (FBD) dementias. The ApoE gene is the major genetic risk factor for sporadic AD. Three major variants of ApoE exist in humans (ApoE2, ApoE3, and ApoE4), with the ApoE4 allele being strongly associated with AD. ITM2b/BRI2 is also a candidate regulatory node genes predicted to mediate the common patterns of gene expression shared by healthy ApoE4 carriers and late-onset AD patients not carrying ApoE4. This evidence provides a direct link between ITM2b/BRI2 and ApoE4. To test whether ApoE4 and pathogenic ITM2b/BRI2 interact to modulate learning and memory, we crossed a mouse carrying the ITM2b/BRI2 mutations that causes FDD knocked-in the endogenous mouse Itm2b/Bri2 gene (FDD KI mice) with human ApoE3 and ApoE4 targeted replacement mice. The resultant ApoE3, FDD KI /ApoE3, ApoE4, FDD KI /ApoE4 male mice were assessed longitudinally for learning and memory at 4, 6, 12, and 16-17 months of age. The results showed that ApoE4-carrying mice displayed spatial working/short-term memory deficits relative to ApoE3-carrying mice starting in early middle age, while long-term spatial memory of ApoE4 mice was not adversely affected even at 16-17 months, and that the FDD mutation impaired working/short-term spatial memory in ApoE3-carrying mice and produced impaired longterm spatial memory in ApoE4-carrying mice in middle age. The present results suggest that the FDD mutation may differentially affect learning and memory in ApoE4 carriers and non-carriers.
Introduction
Alzheimer's disease (AD), the most common neurodegenerative disease among the elderly, is characterized clinically by progressive memory loss and cognitive decline and pathologically by neuropathological markers such as extracellular deposits of amyloid beta (Ab) peptides as neuritic plaques and intracellular neurofibrillary tangles (Selkoe, 1991 (Selkoe, , 2011 . Ab peptides are produced by sequential proteolysis of APP by b-and c-secretases. Mutations in APP and two genes coding for the catalytic subunit of the c-secretases -PSEN1 and PSEN2 -are linked to FAD (Hardy, 1997; Selkoe, 2002; Sherrington et al., 1995) .
ApoE is a 299-amino-acid glycoprotein involved in lipid transport and cholesterol homeostasis (Mahley, 1988) . In the brain, ApoE is synthesized and secreted mainly by astrocytes and is a major component of high-density lipoprotein particles (Beffert et al., 1998; Boyles, Pitas, Wilson, Mahley, & Taylor, 1985; Pitas, Boyles, Lee, Hui, & Weisgraber, 1987) . ApoE fulfills several functions in brain (Beffert et al., 1998) . Cholesterol released from ApoE-containing lipoprotein particles is utilized to support synaptogenesis and the maintenance of synaptic connections (Pfrieger, 2003) . In response to neuronal damage or degeneration, ApoE engages in clearance and redistribution of lipid and cholesterol debris, serving as a scavenger of lipophilic molecules during nerve regeneration (Hauser, Narayanaswami, & Ryan, 2011) . The three major isoforms -ApoE2, ApoE3, and ApoE4 -result from three allelic variants of a single gene on chromosome 19 (Weisgraber, Rall, & Mahley, 1981; Zannis & Breslow, 1981) . Of these, the ApoE4 allele has been identified as the major genetic risk factor for lateonset familial and sporadic AD, and its gene dose is correlated with increased risk and earlier age at onset of the disease (Corder et al., 1993; Saunders et al., 1993) , although the risk of developing AD attributable to ApoE4 varies by geographical region (Bosco et al., 2005; Crean et al., 2011; Panza et al., 1999) and by race and ethnicity (Tang et al., 1996 (Tang et al., , 1998 . In addition, ApoE4 has been shown to
